Envision Healthcare
EVHC
Delayed Nyse - 05/24 05:10:25 pm
55.61USD
+0.09%
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 20162017
Sales3 6967 945
EBITDA6311 062
Operating profit (EBIT)568932
Pre-Tax Profit (EBT)--
Net income-27,7118
EPS ( $ )-0,470,46
Dividend per Share ( $ )--
Yield--
Announcement Date02/28/2017
09:15pm
-
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 20162017
Debt5 5075 470
Finance--
Operating income (EBITDA)6311 062
Leverage
(Debt/EBITDA)
8,73x5,15x
Capital Expenditure99,5140
Book Value Per Share (BVPS)57,3 $55,1 $
Cash Flow per Share6,66 $5,26 $
Announcement Date02/28/2017
09:15pm
-
Balance Sheet Analysis
Financial Ratios
Size 2017e 2018e
Capitalization 6 530 M$ -
Entreprise Value (EV) 12 000 M$ 11 259 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS) 122x 17,6x
Capitalization / Revenue 0,82x 0,73x
EV / Revenue 1,51x 1,26x
EV / EBITDA 11,3x 9,36x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 1,01x 0,96x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 11,7% 11,9%
operating Leverage (Delta EBIT / Delta Sales) 0,56x 1,14x
Net Margin (Net Profit / Revenue) 1,49% 4,51%
ROA (Net Profit / Asset) 2,60% 3,20%
ROE (Net Profit / Equities) 6,45% 7,66%
Rate of Dividend - -
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   1,76% 1,20%
Cash Flow / Sales 7,78% 9,48%
Capital Intensity (Assets / Sales) 0,57x 1,41x
Financial Leverage (Net Debt / EBITDA) 5,15x 3,93x
Price Earning Ratio
BNA & Dividende